title: Review: rivaroxaban causes less fatal bleeding, but does not reduce mortality, compared with VKAs.
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Witt
mesh_terms: D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009025:Morpholines / Q000009:adverse effects*; D013876:Thiophenes / Q000009:adverse effects*
chemical_list: D009025:Morpholines; D013876:Thiophenes